Clinical Trials Logo

Bipolar Depression clinical trials

View clinical trials related to Bipolar Depression.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06126198 Enrolling by invitation - Clinical trials for Major Depressive Disorder

rTMS Feasibility Study on Adolescent Depression Stimulation

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This is an open-label study, in which all participants receives an active treatment with repetitive transcranial magnetic stimulation (rTMS) according to clinical protocol. The aim with this pilotstudy is to investigate the feasibility to perform a trial of low-frequency rTMS on treatment-resistant depression in adolescents. The study includes adolescents 13-19 years old, with average to severe depression.

NCT ID: NCT03567681 Enrolling by invitation - Bipolar Depression Clinical Trials

Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression

Start date: June 13, 2018
Phase: Phase 4
Study type: Interventional

Consenting subjects with Bipolar depression will remain under the care of their local (psychiatric) care provider and be randomized to a six week course of one of two forms of oxcarbazepine (extended release or immediate release. Study outcomes will be assessed based on outcome measures administered to the subject at home by a computer simulated rater. Local care providers will receive "pre-assessment" reports ahead of each clinical visit, rate the Clinical Global Impression for Severity, and evaluate adverse effects. The primary outcome variable is "treatment effectiveness" operationally defined as the response rate X the completion rate.

NCT ID: NCT03349528 Enrolling by invitation - Bipolar Depression Clinical Trials

Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression

Start date: December 11, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.